ACE2 and COVID-19: The induction of TNF-α by SARS-CoV-2 infection and the subsequent upregulation of ACE2 and TMPRSS2 in cardiomyocytes may partially explain the high incidence of cardiac involvement in hospitalized COVID-19 patients [29,31,32].